netFormulary Birmingham, Sandwell, Solihull and environs APC Formulary NHS
Maintained by Midlands and Lancashire Commissioning Support Unit  
 Search
 Formulary Chapter 7: Obstetrics, Gynaecology, and urinary-tract disorders - Full Chapter
07.04.05  Expand sub section  Drugs for erectile dysfunction
Vacuum pumps
View adult BNF View SPC online View childrens BNF
Formulary Green Traffic Light  Available in line with SLS criteria


Red Traffic Light  If use not in line with SLS criteria

  • Use device with lowest acquisition cost 
  •    
    07.04.05  Expand sub section  Alprostadil
    Alprostadil cream (Vitaros®)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    Specialist initiation
  • For patients who would otherwise use alprostadil injection. 
  •    
    Alprostadil Intracavernosal injection
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
     
       
    07.04.05  Expand sub section  Phosphodiesterase type 5 inhibitors
    Sildenafil tablets GENERIC
    View adult BNF View SPC online View childrens BNF
    First Choice
    Green
  • no restrictions on quantity to be supplied to ensure adequate trial of treatment
  • SLS criteria no longer apply


    For use in digital ulceration, see chapter 10 
  • Tadalafil tablets 10mg, 20mg ONLY (Cialis®)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    High Cost Medicine
  • on demand preparation only
  • SLS criteria still apply
  • quantities in line with HSC guidance
    (max 4 tablets per month)  
  • Link  NICE TA273: Hyperplasia (benign prostatic) - tadalafil (terminated appraisal) (TA273)
       
    07.04.05  Expand sub section  Papaverine and phentolamine
    Aviptadil 25mcg / Phentolamine 2mg  (Invicorp®)
    (intracavernosal injection)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
  • Approved on formulary December 2017
  • Specialist initiation.
  • 3rd line after oral PDE-5 inhibitors failed and patient not responding to or intolerant of alprostadil.
  • To be reviewed within 12 months to assess alprostadil supply issues and patent expiry 
  •    
     ....
     Non Formulary Items
    Alprostadil  (MUSE®)

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
    Avanafil  (Spedra®)

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
    Dapoxetine  (Priligy®)

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
    Papaverine

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
    Sildenafil chewable tablets  (Nipatra®)

    View adult BNF View SPC online View childrens BNF
    Non Formulary Discontinued October 2017
     
    Tadalafil once daily

    View adult BNF View SPC online View childrens BNF
    Non Formulary
    Black
  • In line with NHS England's Guidance for CCGs: Items which should not routinely be prescribed in primary care (Dec 2017)

    Click here to access guidance
  • Link  Patient Information Leaflet
    Link  UKMI Q&A: Evidence for the use of regular, rather than on-demand dosing of phosphodiesterase-5 inhibitors after radical prostatectomy
     
    Vardenafil  (Levitra®)

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
      
    Key
    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Unlicensed
    Track Changes
    Display tracking information
    click to search medicines.org.uk
    Link to adult BNF
    click to search medicines.org.uk
    Link to children's BNF
    click to search medicines.org.uk
    Link to SPCs
    Cytotoxic Drug
    Cytotoxic Drug
    CD
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHSE
    NHS England
    Homecare
    Homecare
    CCG
    CCG

    Traffic Light Status Information

    Status Description

    Green

    Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications.  

    Amber

    Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate, or initiation and maintenance of prescribing in Primary Care following recommendation from a Specialist.

    Some amber medicines require agreement with the local (internal) medicines committee prior to initiation; others may require a framework to support safe transfer and maintenance of care such as a RICaD or ESCA. The Formulary will be annotated to reflect these requirements.   

    Red

    Medicines for initiation and maintenance prescribing by Specialists only  

    Black

    Non-formulary medicines- medicines not recommended for routine primary care prescribing.  

    Grey

    Positive NICE TA and /or awaiting local clarification on place in therapy ; Please contact your Medicines Optimisation team for more information.  

    netFormulary